David L. Selwood

Gower Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

A modified cyclosporine enhances lentivector transduction ex vivo and in vivo by degrading IFITM3.

A modified cyclosporine enhances lentivector transduction ex vivo and in vivo by degrading IFITM3.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 21, 2026

Multiple sclerosis and autoimmunity: learnings from post-streptococcal autoimmunity.

Multiple sclerosis and autoimmunity: learnings from post-streptococcal autoimmunity.

Journal: Multiple sclerosis and related disorders

Published: January 06, 2026

Pathogenic variants in the autophagy-tethering factor EPG5 drive neurodegeneration through mitochondrial dysfunction and innate immune activation.

Pathogenic variants in the autophagy-tethering factor EPG5 drive neurodegeneration through mitochondrial dysfunction and innate immune activation.

Journal: Nature communications

Published: June 04, 2025

Quinoline-Based Neuropilin‑1 Antagonists Exhibit a Pure Antagonist Profile and Block Vascular Endothelial Growth Factor-Induced Pain.

Quinoline-Based Neuropilin‑1 Antagonists Exhibit a Pure Antagonist Profile and Block Vascular Endothelial Growth Factor-Induced Pain.

Journal: ACS pharmacology & translational science

Published: January 10, 2025

The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis.

The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis.

Journal: Brain : a journal of neurology

Published: December 09, 2024

Delocalized quinolinium-macrocyclic peptides, an atypical chemotype for CNS penetration.

Delocalized quinolinium-macrocyclic peptides, an atypical chemotype for CNS penetration.

Journal: Science advances

Published: July 10, 2024

Neuroprotection in an Experimental Model of Multiple Sclerosis via Opening of Big Conductance, Calcium-Activated Potassium Channels.

Neuroprotection in an Experimental Model of Multiple Sclerosis via Opening of Big Conductance, Calcium-Activated Potassium Channels.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 23, 2023

Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCV.

Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCV.

Journal: Nature communications

Published: February 28, 2023

Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease.

Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease.

Journal: Cells

Published: March 28, 2022

A Series of Substituted Bis-Aminotriazines Are Activators of the Natriuretic Peptide Receptor C.

A Series of Substituted Bis-Aminotriazines Are Activators of the Natriuretic Peptide Receptor C.

Journal: Journal of medicinal chemistry

Published: March 25, 2022

VEGFA, B, C: Implications of the C-Terminal Sequence Variations for the Interaction with Neuropilins.

VEGFA, B, C: Implications of the C-Terminal Sequence Variations for the Interaction with Neuropilins.

Journal: Biomolecules

Published: December 22, 2021

Oligodendrocytes, BK channels and the preservation of myelin.

Oligodendrocytes, BK channels and the preservation of myelin.

Journal: F1000Research

Published: November 02, 2021

Showing 1-12 of 64

Last Updated: 09/26/2026